|
TIMM9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01727523574391E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.799630E-02 |
| Normal-vs-Stage3 |
3.518900E-03 |
| Normal-vs-Stage4 |
1.263730E-02 |
| Stage1-vs-Stage2 |
9.018500E-03 |
| Stage1-vs-Stage3 |
1.599360E-03 |
| Stage1-vs-Stage4 |
2.568100E-02 |
| Stage2-vs-Stage3 |
9.052800E-01 |
| Stage2-vs-Stage4 |
7.726600E-01 |
| Stage3-vs-Stage4 |
8.472400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.74265071659374E-12 |
| Normal-vs-AfricanAmerican |
9.68559999999785E-05 |
| Normal-vs-Asian |
1.507430E-01 |
| Caucasian-vs-AfricanAmerican |
5.105400E-01 |
| Caucasian-vs-Asian |
7.317600E-01 |
| AfricanAmerican-vs-Asian |
5.327800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.37030436681607E-11 |
| Normal-vs-Female |
7.38450001147584E-09 |
| Male-vs-Female |
8.280400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.564300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.90009996625662E-09 |
| Normal-vs-Age(61-80Yrs) |
7.29149962630515E-10 |
| Normal-vs-Age(81-100Yrs) |
1.193030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.122600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.382000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.480400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.849400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.501000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.975200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.46810000000109E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
3.66099999999925E-05 |
| Normal-vs-Grade 4 |
3.998200E-01 |
| Grade 1-vs-Grade 2 |
4.096600E-01 |
| Grade 1-vs-Grade 3 |
5.399200E-03 |
| Grade 1-vs-Grade 4 |
1.336360E-03 |
| Grade 2-vs-Grade 3 |
3.60769999999677E-05 |
| Grade 2-vs-Grade 4 |
3.962200E-04 |
| Grade 3-vs-Grade 4 |
2.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.423840E-02 |
| ccA subtype-vs-ccB subtype |
3.85880000175476E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35089999689464E-08 |
| Normal-vs-N1 |
1.287840E-01 |
| N0-vs-N1 |
3.684800E-03 |
|
|
